乐天堂fun88

Four scholars and experts from Corvinus University of Budapest, including a member of the Hungarian Academy of Engineering, visited Shenzhen-Hong Kong Cell Valley to discuss innovation cooperation an

Date:03-13  Hits:  Belong to:News & Events

Recently, four scholars and experts from Corvinus University of Budapest in Hungary visited Shenzhen-Hong Kong Cell Valley to exchange ideas on topics such as technological innovation, interdisciplinary research, industrial collaboration, and international cooperation. This visit further enhanced mutual understanding and laid a solid foundation for future collaboration in building an innovation ecosystem, linking international resources, and fostering cooperation in cutting-edge fields.

 

The four visiting scholars were: Dr. Péter Baranyi 、, Director of the Corvinus Advanced Research Institute and Member of the Hungarian Academy of Engineering; Dr. Tamás Bartus, Vice President of Corvinus University and Professor at the Institute of Social and Political Sciences; Dr. Nikolett Deutsch, Director of the University's Institute of Entrepreneurship and Innovation and Full Professor; and Dr. Éva Pintér, Deputy Director of the Institute of Entrepreneurship and Innovation and Assistant Professor at the Institute of Information Systems. The four scholars possess profound academic expertise and international influence in fields such as innovation management, strategic management, cognitive information and communication, and social science research.

During the exchange, Shenzhen-Hong Kong Cell Valley introduced its corporate development history, platform achievements, international layout, and future strategic direction, with a focus on showcasing its exploration and practices in industrialization of cell and gene therapy, cross-border collaboration, and platform service capabilities. The visiting experts expressed strong interest in Cell Valley's approach of leveraging the Guangdong-Hong Kong-Macao Greater Bay Area to connect international resources and promote the integration of cutting-edge technology with industrial development. They also engaged in in-depth discussions on topics such as building an innovation ecosystem, international talent collaboration, and interdisciplinary cooperation mechanisms.


The visiting scholars noted that Corvinus University has strong academic foundations and international collaboration experience in innovation research, strategic technology management, cognitive information and communication, and social system studies. They look forward to further strengthening communication with Shenzhen-Hong Kong Cell Valley in the future, exploring more opportunities for collaboration in academic exchanges, international cooperation, innovation project alignment, and high-level talent interaction.

 

Mr. Shi Yuan Yuan, Chairman of Cell Valley Group, stated that the global development of biomedicine and cutting-edge technologies is rapidly advancing into a new phase characterized by interdisciplinary integration and international collaboration. The visit by Hungarian experts and scholars not only presents a new opportunity for the company to expand its access to European innovation resources and deepen international cooperation but also helps further enhance Shenzhen-Hong Kong Cell Valley's connectivity and platform influence within the global innovation network. In the future, Shenzhen-Hong Kong Cell Valley will continue to uphold the philosophy of open collaboration, actively connecting with top-tier universities, research institutions, and industry partners worldwide to facilitate the translation of more high-level international exchange outcomes in the Guangdong-Hong Kong-Macao Greater Bay Area, injecting new momentum into the high-quality development of the biomedicine and cutting-edge technology industries.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@wfzydp.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Shenzhen Cell Valley Biopharmaceutical Co., Ltd. is a leading one-stop comprehensive outsourcing service provider for China’s cell and gene therapy industry. It is also among the first domestic CRO/CDMO enterprises to hold GMP-compliant industrial production capabilities for clinical-grade retroviral vectors. As a key project for the construction of Shenzhen’s public technical service platform for CRO/CDMO, the company has been listed in the city’s newly announced "20+8" strategic emerging industries initiative.
Shenzhen Cell Valley is equipped with the capacity to conduct standardized and industrialized production of GMP-grade cellular products including CAR-T cells. Its core production lines cover a full spectrum of cellular products such as CAR-T, CAR-NK, CAR-M, γδT, TIL and TCR-T. In addition, the company runs production lines for a diverse range of viral vectors (including RVV, LVV and AAV) and non-viral vectors, as well as for cellular raw materials for therapeutic development—such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses and vaccines.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software